ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,356.83
-0.16%
Dow Jones
39,671.04
-0.51%
Gold vs US Dollar
2,362.89
-0.80%
Brent Oil
81.60
0.09%
Bitcoin
69,735.42
0.92%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Standard BioTools Inc (LAB)

  7. Standard BioTools Inc (LAB) News

Standard BioTools (LAB)

Standard BioTools Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LAB
DateTimeSourceHeadlineSymbolCompany
23/05/202400:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
22/05/202421:54Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:LABStandard BioTools Inc
22/05/202421:01GlobeNewswire Inc.Standard BioTools to Participate in Upcoming Investor ConferencesNASDAQ:LABStandard BioTools Inc
21/05/202422:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
21/05/202422:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
21/05/202422:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
21/05/202422:16Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:LABStandard BioTools Inc
21/05/202422:15Edgar (US Regulatory)Form DEFC14A - Definitive proxy statement, contested solicitationsNASDAQ:LABStandard BioTools Inc
20/05/202413:00GlobeNewswire Inc.Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:LABStandard BioTools Inc
20/05/202411:03Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:LABStandard BioTools Inc
18/05/202401:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
17/05/202402:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
10/05/202422:16Edgar (US Regulatory)Form PREC14A - Preliminary proxy statements, contested solicitationsNASDAQ:LABStandard BioTools Inc
09/05/202421:53Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LABStandard BioTools Inc
08/05/202421:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
08/05/202421:01GlobeNewswire Inc.Standard BioTools Reports First Quarter 2024 Financial ResultsNASDAQ:LABStandard BioTools Inc
25/04/202413:01GlobeNewswire Inc.Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable GrowthNASDAQ:LABStandard BioTools Inc
25/04/202413:00GlobeNewswire Inc.Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024NASDAQ:LABStandard BioTools Inc
08/04/202413:00GlobeNewswire Inc.Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue ImagingNASDAQ:LABStandard BioTools Inc
03/04/202421:01GlobeNewswire Inc.Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine ResearchNASDAQ:LABStandard BioTools Inc
18/03/202412:12GlobeNewswire Inc.Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common StockNASDAQ:LABStandard BioTools Inc
07/03/202400:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
28/02/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
28/02/202421:01GlobeNewswire Inc.Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:LABStandard BioTools Inc
26/02/202421:15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:LABStandard BioTools Inc
26/02/202413:00GlobeNewswire Inc.Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen SequencingNASDAQ:LABStandard BioTools Inc
22/02/202422:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
22/02/202421:05GlobeNewswire Inc.Standard BioTools to Participate in Upcoming Investor ConferencesNASDAQ:LABStandard BioTools Inc
14/02/202420:32Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:LABStandard BioTools Inc
14/02/202413:30GlobeNewswire Inc.Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024NASDAQ:LABStandard BioTools Inc
 Showing the most relevant articles for your search:NASDAQ:LAB

Your Recent History

LSE
AV.
Aviva
LSE
POS
Plexus
LSE
AAZ
Anglo Asian Mining
LSE
ITV
Itv
LSE
GCM
Gcm Resources
LSE
VAST
Vast Resources
LSE
NG.
National Grid
LSE
BMS
Braemar
LSE
VRS
Versarien
LSE
GKP
Gulf Keystone Petroleum
LSE
ITM
Itm Power
LSE
GGP
Greatland Gold
LSE
CNR
Condor Gold
LSE
RR.
Rolls-royce
LSE
AET
Afentra
LSE
IOF
Iofina
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved